Profound Medical (TSE:PRN) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts and uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Profound Medical has partnered with Siemens Healthineers to offer an innovative MRI-guided prostate therapy combining Profound’s TULSA-PRO system with Siemens’ Magnetom Free.Max scanner. This collaboration aims to enhance the precision and accessibility of prostate treatments, benefiting patients with various prostate conditions.
For further insights into TSE:PRN stock, check out TipRanks’ Stock Analysis page.
